toms developing with several of the cephalosporins -notably, cefuroxime and cephalexin,' cephalothin and cephaloridine,' 2 and cephacetrile, ceftazidime, and cefazolin. The health protection branch of Health and Welfare Canada, as well as one of the Canadian manufacturers of cefazolin, each lists two putative cases, though the evidence is anecdotal only (personal communication) . This patient presented with classical changes in consciousness and mentation of a delerium or acute confusional state. While postcardiotomy delerium occurs in up to 28% of patients,4 it tends to be brief and responds well to low dose haloperidol and reorientation in a quiet environment. As other organic causes had been adequately ruled out and there was no evidence of a functional aetiology we thought an adverse drug reaction was the most likely cause and cefazolin the most likely offending agent. Though found. Treatment with captopril was stopped and the patient received diclofenac and subsequently naproxen. Two weeks later he was entirely asymptomatic and the false positive result was no longer present. The patient declined rechallenge with captopril.
There have been reports of a serum sickness like syndrome with arthralgia, rash, and membranous glomerulopathy that resolved in two weeks.2 Urticaria with arthralgia that resolved on withdrawal of captopril has also been described,"4 but a false positive Venereal Disease Research Laboratory test result has not been associated with captopril. The mechanism for this effect is unclear, but captopril has a similar structure and metabolite profile to penicillamine. We suggest that the prevalence of "silent" autoantibodies in the serum of patients receiving captopril should be determined6 and that captopril may rarely cause a drug induced autoimmune disorder in susceptible individuals. Reversible renal failure is a well known side effect of angiotensin converting enzyme inhibitors in patients with severe renovascular disease. Renal artery occlusion associated with the use of angiotensin converting enzyme inhibitors has been reported,' but we report a further case with important differences from the previous ones. Over six months difficulty was experienced in controlling the blood pressure of a 71 year old woman who was an ex-smoker. Initial treatment included captopril and was associated with a pronounced fall in blood pressure and a rise in plasma creatinine concentration from 153 to 222 [tmol/l over three weeks. Captopril was stopped and creatinine fell gradually to 135 tmol/Il in association with loss of blood pressure control. Intravenous urography showed a normal left kidney and a small right kidney with a faint but persistent nephrogram. The patient was treated with various combinations of nifedipine, methyldopa, frusemide, and prazosin, and plasma creatinine fluctuated between 133 and 210 itmol/l. After she developed clinical and radiographic features of pulmonary oedema and side effects of higher doses of prazosin and frusemide treatment was replaced by enalapril 2-5 mg daily, increased after three days to 5 mg with the addition of bumetanide 1 mg/day. Six days after starting enalapril the patient became anuric and developed acute pulmonary oedema. She reported no symptoms of hypotension, and the lowest recorded blood pressure after enalapril was started was 140/70 mm Hg. Despite a good symptomatic response to intravenous diamorphine, frusemide, and isosorbide dinitrate she 'remained anuric over the next 12 hours. A return of symptomatic pulmonary oedema was successfully treated with the removal of 2 litres of fluid in three hours by arteriovenous haemofiltration. Urgent arteriography showed occlusion of the right renal artery and a stenosis of the left renal artery with a distal occluding thrombus. It proved impossible to pass a guidewire through this obstruction despite infusion of streptokinase into the artery. The patient was not fit for surgery, and regular haemodialysis was started. After 10 days she suffered a cardiac arrest and died. Necropsy confirmed the presence of an atheromatous stenosis and recent occlusive thrombus in the left renal artery.
In four reports of six patients developing renal artery occlusion in association with angiotensin converting enzyme inhibitor treatment in native kidneys' the occlusions were discovered several months after treatment started. In each case there was a non-affected kidney, and the diagnosis was made by arteriography. In the one case with a close temporal association' the renal artery thrombosis was attributed to profound hypotension which developed three hours after the first dose of captopril. The important differences in our case were the close temporal association and the absence of hypotension.
It is, of course, possible that renal artery occlusion after several months' treatment simply represented the natural course of the disease, but the close temporal association in our case makes it more likely that the drug was responsible. Tillman et al have suggested that angiotensin converting enzyme inhibitors should be used for one month before definitive treatment in this group of patients,4 so the occurrence of early occlusion is important.
We cannot be sure that this patient did not have an unrecorded asymptomatic hypotensive episode, but the development of pulmonary oedema quickly after the onset of inuria suggests that she was not hypovolaemic at the time of renal artery thrombosis. 
